The risk of developing Alzheimer’s could be predicted before any symptoms start, a new study indicates. A method has been developed by researchers which it's hoped could help speed up the creation of new treatments for the disease.
People with Alzheimer’s experience a gradual loss of memory and other cognitive functions. Currently, some treatments can ease symptoms, but developing treatments which can actually prevent or slow disease progression has been more challenging, reports PA.
Senior author Dr Amit Khera said: “We developed a genetic predictor of Alzheimer’s disease associated with both clinical diagnosis and age-dependent cognitive decline. By studying the circulating proteome of healthy individuals with very high versus low inherited risk, our team nominated new biomarkers of neurocognitive disease.”
